Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Weekly Wrap 22 April

Sophia Mavridis
April 22, 2022

Morning Bell 21 April

Paulina Peters
April 21, 2022

Morning Bell 20 April

Sophia Mavridis
April 20, 2022

Morning Bell 19 April

Paulina Peters
April 19, 2022

Morning Bell 14 April

Paulina Peters
April 14, 2022

Morning Bell 13 April

Sophia Mavridis
April 13, 2022

Morning Bell 12 April

Paulina Peters
April 12, 2022

Morning Bell 11 April

Sophia Mavridis
April 11, 2022

Weekly Wrap 8 April

Sophia Mavridis
April 8, 2022

Morning Bell 7 April

Paulina Peters
April 7, 2022

Morning Bell 6 April

Paulina Peters
April 6, 2022